J Gibassier

Intermethod Variability in TSH-Receptor Antibody Measurement: Implication for the Diagnosis of Graves Disease and for the Follow-Up of Graves Ophthalmopathy

Catherine Massart, Rémy Sapin, J Gibassier et al. · Clinical Chemistry · 2008 · 42 citations · Full text

Doxorubicin Induces Fas-Mediated Apoptosis in Human Thyroid Carcinoma Cells

Catherine Massart, Romain Barbet, N Génetet et al. · Thyroid · 2004 · 30 citations

Ftc 133, Cytotoxic Effects, Oncology +12

Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: Comparison with the second generation human TRAb assay

Catherine Massart, J Gibassier, M. D’Herbomez · Clinica Chimica Acta · 2009 · 25 citations

Translational Medicine, Medicine, Thyroid Disease +8

Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves’ disease

E. Sonnet, Catherine Massart, J Gibassier et al. · Journal of Endocrinological Investigation · 1999 · 23 citations

Inflammation, Immunology, Pathology +5

Effect of sodium butyrate on doxorubicin resistance and expression of multidrug resistance genes in thyroid carcinoma cells

Catherine Massart, Charles Poirier, Patricia Fergelot et al. · Anti-Cancer Drugs · 2005 · 21 citations

Tumor Biology, Ftc 133, Oncology +15